Details

Autor(en) / Beteiligte

• Beyer, J.
• Albers, P.
• Altena, R.
• Aparicio, J.
• Bokemeyer, C.
• Busch, J.
• Cathomas, R.
• Cavallin-Stahl, E.
• Clarke, N.W.
• Claßen, J.
• Cohn-Cedermark, G.
• Dahl, A.A.
• Daugaard, G.
• De Giorgi, U.
• De Santis, M.
• De Wit, M.
• De Wit, R.
• Dieckmann, K.P.
• Fenner, M.
• Fizazi, K.
• Flechon, A.
• Fossa, S.D.
• Germá Lluch, J.R.
• Gietema, J.A.
• Gillessen, S.
• Giwercman, A.
• Hartmann, J.T.
• Heidenreich, A.
• Hentrich, M.
• Honecker, F.
• Horwich, A.
• Huddart, R.A.
• Kliesch, S.
• Kollmannsberger, C.
• Krege, S.
• Laguna, M.P.
• Looijenga, L.H.J.
• Lorch, A.
• Lotz, J.P.
• Mayer, F.
• Necchi, A.
• Nicolai, N.
• Nuver, J.
• Oechsle, K.
• Oldenburg, J.
• Oosterhuis, J.W.
• Powles, T.
• Rajpert-De Meyts, E.
• Rick, O.
• Rosti, G.
• Salvioni, R.
• Schrader, M.
• Schweyer, S.
• Sedlmayer, F.
• Sohaib, A.
• Souchon, R.
• Tandstad, T.
• Winter, C.
• Wittekind, C.

Titel

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

Ist Teil von

• Annals of oncology, 2013-04, Vol.24 (4), p.878-888

Ort / Verlag

Oxford: Elsevier Ltd

Erscheinungsjahr

2013

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• In November 2011, the Third European Consensus Conference on Diagnosis and Treatment of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed similar meetings in 2003 (Essen, Germany) and 2006 (Amsterdam, The Netherlands) [Schmoll H-J, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ-cell cancer: a report of the European Germ-Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377–1399; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008; 53: 478–496; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part II. Eur Urol 2008; 53: 497–513]. A panel of 56 of 60 invited GCC experts from all across Europe discussed all aspects on diagnosis and treatment of GCC, with a particular focus on acute and late toxic effects as well as on survivorship issues. The panel consisted of oncologists, urologic surgeons, radiooncologists, pathologists and basic scientists, who are all actively involved in care of GCC patients. Panelists were chosen based on the publication activity in recent years. Before the meeting, panelists were asked to review the literature published since 2006 in 20 major areas concerning all aspects of diagnosis, treatment and follow-up of GCC patients, and to prepare an updated version of the previous recommendations to be discussed at the conference. In addition, ∼50 E-vote questions were drafted and presented at the conference to address the most controversial areas for a poll of expert opinions. Here, we present the main recommendations and controversies of this meeting. The votes of the panelists are added as online supplements.